Mounjaro 2.5mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Mounjaro 2.5mg Injection
contains Tirzepatide 2.5mg in a once-weekly pre-filled KwikPen, and is the starting dose for Mounjaro therapy. Tirzepatide is the first and only dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, offering a novel dual-hormone mechanism that produces superior weight loss and glycaemic control compared to GLP-1-only agents.
Benefits:
- First-in-class dual GIP/GLP-1 receptor agonist mechanism
- Initiates treatment with a low dose to improve tolerability
- Lays the foundation for achieving 20%+ body weight reduction at maintenance doses
- Improves both fasting and postprandial blood glucose
- Demonstrated superiority over semaglutide in head-to-head SURMOUNT trials
How It Works:
Tirzepatide simultaneously activates both GIP and GLP-1 receptors. GIP receptor activation augments insulin secretion, promotes adipocyte lipid uptake, and reduces GI side effects compared to GLP-1 agonism alone. GLP-1 receptor activation suppresses appetite, slows gastric emptying, and stimulates further insulin secretion. The combined dual-hormone signalling produces greater metabolic effect than either mechanism alone, explaining the superior efficacy of tirzepatide over semaglutide.
Dosage and Administration:
Inject 2.5mg subcutaneously once weekly for 4 weeks into the abdomen, thigh, or outer upper arm. Can be given at any time of day, with or without meals. Rotate injection sites. After 4 weeks, escalate to 5mg. Each KwikPen delivers a single dose and is then discarded.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, decreased appetite, abdominal discomfort. Injection-site: redness, bruising, pain. Uncommon: headache, increased heart rate, fatigue, dizziness. Serious: pancreatitis, cholelithiasis, diabetic retinopathy complications.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Use with caution in patients with a history of pancreatitis. Monitor for gallbladder disease, especially during rapid weight loss.
Mounjaro Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 2.5mg | Lower strength option | 4–8 wks | Weekly | Current |
| 5mg | Standard strength option | 4–8 wks | Weekly | View → |
| 7.5mg | Popular strength option | 4–8 wks | Weekly | View → |
| 10mg | Popular strength option | 4–8 wks | Weekly | View → |
| 12.5mg | Higher strength option | 4–8 wks | Weekly | View → |
| 15mg | Maximum strength variant | 4–8 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Mounjaro 2.5mg used for?
Mounjaro 2.5mg is the starting dose of tirzepatide used for weight management in adults with obesity or overweight with comorbidities, and for glycaemic control in type 2 diabetes. The 2.5mg dose is a tolerability initiation dose only.
Q2: How is Mounjaro different from Wegovy or Ozempic?
Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors, while Wegovy and Ozempic (semaglutide) activate only GLP-1 receptors. This dual mechanism gives Mounjaro superior efficacy — clinical trials show average weight loss of 20–22% versus 15% for Wegovy at equivalent trial durations.
Q3: Is 2.5mg tirzepatide enough to lose weight?
The 2.5mg initiation dose is not a therapeutic weight-loss dose. It is designed for tolerability. Weight-loss benefit begins to build as the dose is escalated toward 5mg, 10mg, and 15mg.
Q4: How long do I take Mounjaro 2.5mg before increasing the dose?
Mounjaro 2.5mg is taken for exactly 4 weeks. After that, your prescriber will increase the dose to 5mg, with subsequent escalations every 4 weeks as tolerated until reaching the target maintenance dose.
Q5: Does each Mounjaro pen deliver only one dose?
Yes. Each Mounjaro KwikPen contains a single pre-measured dose. After one subcutaneous injection, the pen is discarded. A new pen is used for each weekly injection.
Q6: Can Mounjaro 2.5mg be used with metformin?
Yes. Tirzepatide is frequently combined with metformin in type 2 diabetes management, providing complementary glycaemic control through different mechanisms. No significant drug interaction exists between the two.
Q7: What are the signs that Mounjaro is working?
Early signs include reduced hunger, feeling full sooner during meals, mild weight loss, and improved fasting blood glucose readings. These effects typically become more pronounced as the dose escalates.
Q8: Does Mounjaro require refrigeration?
Unused pens must be refrigerated at 2–8°C. Once in use or at room temperature, the pen can be kept for up to 21 days at temperatures below 30°C. Never freeze Mounjaro pens.
Q9: Can I use Mounjaro if I have severe kidney disease?
Mounjaro can be used with caution in mild to moderate chronic kidney disease. In severe renal impairment, there is limited data. Your prescriber will weigh the benefit-risk profile and may choose an alternative.
Q10: Is Mounjaro approved for weight loss without diabetes?
Tirzepatide received FDA and EMA approval for chronic weight management (as Zepbound brand in the US) in adults with obesity or overweight with comorbidities, regardless of diabetes status. Prescribers may use either the Mounjaro or Zepbound formulation depending on market and indication.
Customer Reviews
Dr. James Wilson
USA · 1 week ago
“Excellent product quality. Arrived well-packaged with proper cold chain maintained throughout transit. Will order again.”
Priya Sharma
India · 1 month ago
“Prompt response from the team and smooth ordering process. Medicine arrived in original sealed packaging as expected.”
FirstCare Clinic
Canada · 3 months ago
“Good value for bulk procurement orders. Communication was clear and the shipment arrived within the estimated timeframe.”
Dr. Maria Santos
Australia · 3 weeks ago
“Good quality product. Shipping was fast and handled with care. Would recommend for professional hospital procurement.”
Michael K.
USA · 2 months ago
“Fast international shipping and professional packaging. Product was exactly as described. Highly recommend this supplier.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.